The mirogabalin ALDAY phase 3 program in pain associated with fibromyalgia: the lessons learned-Reference-Cited by-同舟云学术

The mirogabalin ALDAY phase 3 program in pain associated with fibromyalgia: the lessons learned

Published:2020-02-23 Issue:4 Volume:36 Page:661-666
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Merante Domenico¹

Affiliation:

1. Global Clinical Development, Amersham, UK

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2020.1725744

Reference25 articles.

1. Efficacy and Safety of Mirogabalin (DS-5565) for the Treatment of Diabetic Peripheral Neuropathic Pain: A Randomized, Double-Blind, Placebo- and Active Comparator–Controlled, Adaptive Proof-of-Concept Phase 2 Study

2. Daiichi Sankyo announces marketing approval in Japan of “Tarlige® tablets” for pain treatment. 8 January 2019 [cited 2019 Dec 31]. Available from: https://www.daiichisankyo.com/media_investors/media_relations/press_releases/detail/006959.html.

3. Fibromyalgia: is it a neuropathic pain?

4. Small fibre pathology in patients with fibromyalgia syndrome

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel drug treatments for pain in advanced cancer and serious illness: a focus on neuropathic pain and chemotherapy-induced peripheral neuropathy;Palliative Care and Social Practice;2024-01

2. A systematic literature review on the clinical efficacy of low dose naltrexone and its effect on putative pathophysiological mechanisms among patients diagnosed with fibromyalgia;Heliyon;2023-05

3. Content and sentiment analysis of gabapentinoid‐related tweets: An infodemiology study;Drug and Alcohol Review;2022-12-20

4. Mirogabalin as a Novel Gabapentinoid for the Treatment of Chronic Pain Conditions: An Analysis of Current Evidence;Anesthesiology and Pain Medicine;2021-12-22

5. Safety, tolerability, and efficacy of a selective gabapentinoid mirogabalin in neuropathic pain—a topical review;Ain-Shams Journal of Anesthesiology;2021-10-15